次世代がん診断の世界市場は2020年の62億ドルから2025年までに167億ドルに拡大する見込みで、2020−2025年におけるCAGRは21.9%と推定されます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Next Generation Cancer Diagnostics, by Cancer Site, Through 2025
Figure Summary : Global Market for Next Generation Cancer Diagnostics, by Cancer Site, 2019-2025
Chapter- 3: Overview
Large-Scale Initiatives and Consortia
Market Size
Liquid Biopsy as a Market Driving Force
Key Trends
Industry
BCC Research Select Insights from Industry Leaders
Table 1 : Next Generation Cancer Diagnostics: Scope of Report
Chapter- 4: Technologies
Diagnostics Overview
Arrays and Microfluidics (LOAC) Technologies
Multiplex Conventional Technologies
Next Generation Sequencing Technology
Polymerase Chain Reaction (PCR) Technology
Chapter- 5: Liquid Biopsy Technologies
Liquid Biopsy Biomarkers
Cancer Genomics
Circulating Tumor Cell Technologies
CTC Workflow
Cell Isolation Technologies
CTC Sample Preparation Technologies
CTC Downstream Analysis Technologies
Comparison of Liquid Biopsy with Conventional Biopsy
Cancer Testing
Avatar-Driven Diagnostic Approaches
Chapter- 6: Next Generation Cancer Diagnostics: Key Initiatives and Programs
Blood Profiling Atlas
Cancer-ID
Cancer Moon Shots
China Precision Medicine Initiative
ClinGen
CTC Trap Consortium
Early Cancer Detection Consortium
EpiFemCare
France Genomic Medicine Plan
Friends of Cancer Research Project
Human Cell Atlas
Immunomonitor Consortium
Integration of Imaging and Fluid-Based Tumor Monitoring
Liquid Biopsies and Imaging for Improved Cancer Care
Million Veteran Program
MedSeq
Next-Generation Single-Cell Analysis Program
Population Sequencing Projects
Precancer Atlas
Precision Medicine Initiative
Prompt
QuIP Project
Single-Cell Proteomics and Lipidomics Project
TopMed
Treehouse Childhood Cancer Initiative
Very Rare Cancer Consortium
Worldwide Innovative Networking (WIN) Consortium
Single-Cell Research
Population Sequencing Programs
Table 32 : R&D: Next Generation Cancer Diagnostics
Chapter- 7: Next Generation Cancer Diagnostic Applications by Cancer Site
Introduction
Bladder Cancer
Brain Cancer
Breast Cancer
Gynecologic Cancers
Colorectal Cancer
Cancer Unknown Primary
Gastric Cancer
Kidney Cancer
Hematologic Tests: Leukemia and Myeloma
Liver Cancer
Lung Cancer
Hematologic Tests: Lymphomas
Melanoma
Pan-Cancer
Prostate Cancer
Thyroid Cancer
Chapter- 8: Cancer Diagnostics Industries
Sequencing Instruments Industry
Long Read Sequencing Industry
Sequencing Informatics Industry
PCR Industry
Droplet Digital PCR Industry
CTC Capture and Detection Industry
Liquid Biopsy Assay Industry
Chapter- 9: Industry Acquisitions and Strategic Alliances
Acquisitions
Strategic Alliances
Chapter- 10: Cancer Diagnostics Markets
Forces Driving Growth
COVID-19 Impact on Cancer Diagnostic Markets
Cancer Markets
Market for Next Generation Cancer Diagnostics by Cancer Site
Market for Next Generation Cancer Diagnostics by Purpose of Analysis
Market for Next Generation Cancer Diagnostics by Test Platform
Market for Test Platforms by Cancer Site
Market by Diagnostic Segment
Regional Market Analysis
Chapter- 11: Patents
Circulating Tumor Cell Patents
Exosome Patents
Cell-free DNA (cfDNA) Patents
Biomarker-Related Patents
Patent Considerations: AI in Cancer Diagnostics
Chapter- 12: Company Profiles
20/20 GENE SYSTEMS
ABBOTT LABORATORIES
ADAPTIVE BIOTECHNOLOGIES INC.
AGENDIA NV
AGILENT TECHNOLOGIES INC.
AKADEUM LIFE SCIENCES
AMBRY GENETICS
AMOY DIAGNOSTICS CO. LTD.
ANGLE PLC
APOCELL INC.
APOSTLE INC.
ARBOR VITA CORP.
ARCHER DX
AROCELL AB
ARUP LABORATORIES
ASPIRA LABS
ASURAGEN, INC.
ATILA BIOSYSTEMS
AVIVA BIOSCIENCES
BECTON, DICKINSON AND CO.
BGI SHENZHEN
BIOCARTIS NV
BIOCEPT INC.
BIODESIX INC.
BIOFIDELITY LTD.
BIOFLUIDICA INC.
BIOLIDICS LTD.
BIOLOGICAL DYNAMICS INC.
BIOPROGNOS SL
BIOTHERANOSTICS INC.
BIO-TECHNE CORP.
BLUESTAR GENOMICS INC.
CANCER GENETICS INC.
CARIS LIFE SCIENCES
CASTLE BIOSCIENCES INC.
CC DIAGNOSTICS BV
CELCUITY INC.
CELLMAX LIFE
CELLULAR ANALYTICS
CELL MICROSYSTEMS INC.
CELSEE DIAGNOSTICS
CHIP DIAGNOSTICS
CHRONIX BIOMEDICAL
CIRCULOGENE THERANOSTICS
CLINICAL GENOMICS TECHNOLOGIES
CODIAK BIOSCIENCES
DANAHER CORP.
DECIPHER BIOSCIENCES
DERMTECH
DIACARTA INC.
DNALYTICS
EPIGENOMICS AG
EPIC SCIENCES INC.
EXACT SCIENCES CORP.
FLUXION BIOSCIENCES INC.
FREENOME INC.
FULGENT GENETICS INC.
GENECENTRIC THERAPEUTICS
GENEDX INC.
GENERA BIOSYSTEMS
GENESEQ BIOSCIENCES PTY LTD.
GENETRON HEALTH TECHNOLOGIES INC.
GENEOSCOPY LLC
GENEXOSOME TECHNOLOGIES INC.
GRAIL INC.
GUARDANT HEALTH INC.
HOLOGIC INC.
HTG MOLECULAR DIAGNOSTICS INC.
IDL BIOTECH
ILLUMINA INC.
IMMUNIS AI
INCELLDX INC.
INIVATA LTD.
INTERPACE BIOSCIENCES INC.
INVITAE INC.
INVIVOSCRIBE INC.
JBS SCIENCE INC.
LABORATORY CORP. OF AMERICA INC.
LEXENT BIO INC.
LUCENCE DIAGNOSTICS PTE. LTD.
LUNGLIFE AI, INC.
MDNA LIFE SCIENCES INC.
MDXHEALTH INC.
MEDGENOME INC.
MENARINI SILICON BIOSYSTEMS SPA
MIRADX
MIR SCIENTIFIC
MUTANTDX
MY PERSONAL THERAPEUTICS LTD.
MYRIAD GENETICS INC.
NEOGENOMICS LABORATORIES
NEO NEW ONCOLOGY GMBH
NODEXUS
NOVIGENIX SA
NRICH DX
NUCLEIX
NUPROBE INC.
ONCIMMUNE HOLDINGS PLC
ONCOCYTE CORP.
ONCODNA S.A.
OPKO HEALTH
OXFORD GENE TECHNOLOGY
PACIFIC EDGE LTD.
PANGAEA LABORATORY
PANGAEA ONCOLOGY
PERSONAL GENOME DIAGNOSTICS INC.
POLYMEDCO, INC.
PREDICINE INC.
PROVISTA DIAGNOSTICS INC.
QIAGEN NV
QUANTUMDX
QUEST DIAGNOSTICS INC.
RARECYTE INC.
RESOLUTION BIOSCIENCE INC.
ROCHE HOLDING AG
SAGA DIAGNOSTICS AB
SANOMICS LTD.
SIENNA CANCER DIAGNOSTICS LTD.
SINGLERA GENOMICS INC.
SISTEMAS GENOMICOS
SKYLINEDX BV
STAGE ZERO LIFE SCIENCES
STRAND LIFE SCIENCES PVT., LTD.
SYSMEX INOSTICS GMBH
THERMO FISHER SCIENTIFIC INC.
THRIVE EARLIER DETECTION CORP.
TIZIANA LIFE SCIENCES PLC
VORTEX BIOSCIENCES
VERACYTE
VOLITIONRX
XING TECHNOLOGIES LLC
YIKON GENOMICS CO. LTD.
